Please use a minimum of three unique search wordsOur search is configured to only display links relevant to answer your question. For the best results please use specific and relevant keywords that accurately reflect the information you are seeking.Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Humulin ® (human insulin)
Humulin® S, Humulin® I, Humulin® M3 100 Units/ml (insulin human): Effects on ability to drive and use machines
The patient’s ability to concentrate and react may be impaired as a result of hypoglycaemia
The patient’s ability to concentrate and react may be impaired as a result of hypoglycaemia. This may constitute a risk in situations where these abilities are of special importance (e.g. driving a car or operating machinery).
Patients should be advised to take precautions to avoid hypoglycaemia whilst driving, this is particularly important in those who have reduced or absent awareness of the warning signs of hypoglycaemia or have frequent episodes of hypoglycaemia. The advisability of driving should be considered in these circumstances.
Humulin S (soluble insulin) 100 cartridge Summary of Product Characteristics
Humulin S 100 vial Summary of Product Characteristics Characteristics
Humulin I (isophane insulin) 100 cartridge Summary of Product Characteristics
Humulin I 100 SPC KwikPen Summary of Product Characteristics
Humulin I 100 SPC vial Summary of Product Characteristics
Humulin M3 100 KwikPen Summary of Product Characteristics
Humulin M3 100 vial Summary of Product Characteristics
Date of Last Review: May 30, 2019